The NYS Medicaid 1115 Health Equity Reform (HER) Waiver, approved in January 2024, provides $6.7 billion to improve health equity, reduce disparities, and support health-related social needs in New York State. To succeed under this waiver, organizations must conduct comprehensive cost analysis to optimize resource allocation, enhance competitiveness, make informed decisions, and ensure financial sustainability. Key strategies include detailed cost identification, operational reviews, advanced cost controls, enhanced financial reporting, and integrated technology solutions. Understanding the return on investment for Social Determinants of Health (SDOH) programs is essential for demonstrating value and securing ongoing support.
This material has been prepared for general, informational purposes only and is not intended to provide, and should not be relied on for, tax, legal or accounting advice. Should you require any such advice, please contact us directly. The information contained herein does not create, and your review or use of the information does not constitute, an accountant-client relationship.
